How many patents does
Intarcia Therapeutics have?
patents
348
families
37
granted
83
applications
265
US
105
EP
32
CN
21
WO
14
JP
14
KR
8
RoW
154
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Intarcia Therapeutics
Top ten assignees appearing on patents
2009 - 2018
| intarcia therapeutics | 289 |
| alza corporation | 20 |
| intarsija terap'jutiks | 1 |
| intarcia therapeuties | 1 |
| biomedicines | 1 |
2009
| intarcia therapeutics | 38 |
| alza corporation | 12 |
| intarcia therapeuties | 1 |
| biomedicines | 1 |
2018
| intarcia therapeutics | 26 |
Intarcia Therapeutics
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| rapid establishment and/or termination of substantial steady-state drug delivery | 49 | 2009 |
| solvent/polymer solutions as suspension vehicles | 37 | 2005 |
| osmotic delivery systems and piston assemblies | 34 | 2006 |
| suspension formulations of insulinotropic peptides and uses thereof | 26 | 2007 |
| stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles | 25 | 1999 |
| highly concentrated drug particles, formulations, suspensions and uses thereof | 23 | 2008 |
| devices, formulations, and methods for delivery of multiple beneficial agents | 18 | 2008 |
| two-piece, internal-channel osmotic delivery system flow modulator | 16 | 2006 |
| composition and dosage form comprising an amphiphilic molecule as a suspension vehicle | 14 | 2003 |
| implant placement and removal systems | 13 | 2015 |